Rbf Capital »

Cardlytics shares owned by Rbf Capital

Quarter-by-quarter ownership of Cardlytics (CDLX) shares owned by Rbf Capital from 13F filings

Historical chart of Rbf Capital investment in Cardlytics

Tip: Access up to 7 years of quarterly data

All positions including Cardlytics held by Rbf Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cardlytics by Rbf Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.7M 115k 14.49

More positions owned by Rbf Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Morgan Stanley Com New (MS)
Builders FirstSource (BLDR)
Meta Platforms Cl A (META)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Mastercard Incorporated Cl A (MA)
Danaos Corporation SHS (DAC)
Bank of America Corporation (BAC)
UnitedHealth (UNH)
Visa Com Cl A (V)
Hca Holdings (HCA)
Fair Isaac Corporation (FICO)
S&p Global (SPGI)
Microsoft Corporation (MSFT)
Apple (AAPL)

View all positions for Rbf Capital

Top funds holding Cardlytics

BlackRock
Vanguard Group
Morgan Stanley
683 Capital Management
KPS Global Asset Management UK
Worldly Partners Management
Geode Capital Management
State Street Corporation
Baillie Gifford & Co
Marshall Wace
Nuveen Asset Management
Tenzing Global Management
Dimensional Fund Advisors
LPL Financial
Susquehanna International

View all funds holding Cardlytics